Sabine Royalty Trust (SBR) Stock Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SBR Stock Alerts $62.65 +0.18 (+0.29%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Sabine Royalty Trust Stock Price Performance5 Day Performance-0.38%1 Month Performance-1.01%3 Month Performance-3.23%6 Month Performance+7.42%Year-To-Date Performance-7.68%1 Year Performance-15.02% Receive SBR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sabine Royalty Trust and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> SBR Stock Chart for Saturday, April, 27, 2024 SBR Chart by TradingView Sabine Royalty Trust Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$62.46$62.63+0.27%$63.71$62.1027,562 shs$913.15 million04/25/2024$62.73$62.46-0.43%$63.01$62.1419,807 shs$910.67 million04/24/2024$63.01$62.73-0.44%$63.46$62.6816,687 shs$914.54 million04/23/2024$62.89$63.01+0.19%$64.00$62.7613,869 shs$918.69 million04/22/2024$63.82$62.89-1.46%$64.00$62.8018,879 shs$916.94 million04/19/2024$62.35$63.49+1.83%$64.19$62.2035,403 shs$925.68 million Get the Latest News and Ratings for SBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sabine Royalty Trust and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$64.17$62.35-2.84%$64.49$62.2632,634 shs$909.06 million04/17/2024$64.00$64.17+0.27%$65.55$64.0131,556 shs$935.60 million04/16/2024$63.71$64.00+0.46%$64.43$63.0433,716 shs$933.12 million04/15/2024$66.87$63.71-4.73%$67.20$63.4850,100 shs$928.89 million04/12/2024$67.72$66.87-1.26%$68.36$66.7519,678 shs$974.97 million04/11/2024$68.03$67.72-0.46%$68.40$67.4625,913 shs$987.36 million04/10/2024$68.50$68.03-0.69%$68.82$67.8326,461 shs$991.88 million04/09/2024$68.21$68.50+0.43%$68.64$67.5521,434 shs$998.73 million04/08/2024$68.09$68.21+0.18%$69.50$67.7555,391 shs$994.50 million04/05/2024$66.78$68.09+1.96%$68.21$66.6436,460 shs$992.68 million04/04/2024$66.61$66.78+0.26%$66.88$65.8521,609 shs$973.65 million04/03/2024$65.81$66.61+1.22%$66.66$65.3920,876 shs$971.17 million04/02/2024$64.60$65.81+1.87%$65.98$64.3036,358 shs$959.51 million04/01/2024$63.59$64.60+1.59%$64.75$63.3325,847 shs$941.87 million03/29/2024$63.32$63.59+0.43%$63.89$63.0526,829 shs$927.14 million03/28/2024$63.29$63.32+0.04%$63.89$63.0526,813 shs$923.13 million03/27/2024$62.45$63.29+1.35%$63.29$62.5017,211 shs$922.77 million03/26/2024$62.78$62.45-0.53%$62.98$62.3412,997 shs$910.52 million03/25/2024$62.32$62.78+0.74%$63.47$62.2026,058 shs$915.27 million03/22/2024$62.24$62.15-0.14%$62.47$61.9116,556 shs$906.15 million03/21/2024$62.50$62.24-0.42%$62.69$62.0019,430 shs$907.46 million03/20/2024$62.65$62.50-0.24%$62.88$62.3014,465 shs$911.19 million03/19/2024$61.65$62.65+1.62%$62.89$61.5121,499 shs$913.44 million03/18/2024$61.63$61.65+0.03%$61.75$61.2217,373 shs$898.86 million03/15/2024$61.66$61.63-0.05%$62.20$60.7328,908 shs$898.50 million03/14/2024$62.23$61.66-0.92%$61.94$61.0035,582 shs$899.00 million03/13/2024$62.80$62.23-0.91%$62.97$62.0528,916 shs$907.31 million03/12/2024$61.39$62.80+2.30%$62.80$61.2027,139 shs$915.62 million03/11/2024$61.06$61.39+0.54%$61.76$60.8527,428 shs$895.01 million03/08/2024$60.30$60.91+1.01%$61.21$60.3715,420 shs$888.07 million03/07/2024$60.16$60.30+0.23%$60.61$59.9032,751 shs$879.17 million03/06/2024$60.09$60.16+0.12%$60.32$59.8436,872 shs$877.07 million03/05/2024$60.06$60.09+0.04%$60.83$59.9426,550 shs$876.04 million03/04/2024$60.66$60.06-0.99%$61.08$59.9832,003 shs$875.68 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$59.90$60.66+1.27%$60.92$59.6033,173 shs$884.42 million02/29/2024$59.69$59.90+0.35%$60.90$59.5531,531 shs$873.34 million02/28/2024$60.31$59.69-1.03%$60.85$59.3632,707 shs$870.28 million02/27/2024$59.73$60.31+0.97%$60.67$59.6920,001 shs$879.32 million02/26/2024$60.03$59.73-0.50%$60.72$59.5023,321 shs$870.86 million02/23/2024$61.28$60.02-2.06%$61.10$59.8233,762 shs$875.09 million02/22/2024$62.21$61.28-1.49%$62.45$61.0130,038 shs$893.46 million02/21/2024$60.08$62.21+3.55%$62.36$60.4221,761 shs$906.96 million02/20/2024$62.93$60.08-4.53%$63.17$60.0051,775 shs$875.97 million02/19/2024$62.93$62.93$63.30$62.6433,500 shs$917.52 million02/16/2024$62.70$62.93+0.37%$63.30$62.6433,503 shs$917.46 million02/15/2024$62.42$62.70+0.45%$63.32$62.2048,417 shs$914.17 million02/14/2024$62.83$62.42-0.65%$62.94$62.1141,088 shs$910.08 million02/13/2024$63.13$62.83-0.48%$63.30$62.6258,623 shs$916.06 million02/12/2024$62.43$63.13+1.12%$63.75$62.4030,565 shs$920.44 million02/09/2024$62.04$62.43+0.63%$62.84$61.8154,521 shs$910.23 million02/08/2024$61.40$62.04+1.04%$62.21$60.6627,216 shs$904.54 million02/07/2024$60.65$61.40+1.24%$61.54$60.5322,624 shs$895.21 million02/06/2024$58.51$60.65+3.66%$60.99$58.7530,462 shs$884.22 million02/05/2024$59.00$58.51-0.83%$59.24$57.7379,000 shs$853.08 million02/02/2024$59.73$59.00-1.22%$59.99$58.6657,166 shs$860.22 million02/01/2024$61.18$59.73-2.37%$61.73$59.7156,510 shs$870.86 million01/31/2024$62.69$61.18-2.41%$62.96$61.0137,553 shs$892.00 million01/30/2024$63.74$62.69-1.65%$63.94$62.4539,995 shs$914.02 million01/29/2024$64.74$63.74-1.54%$64.94$63.2241,031 shs$929.33 million01/26/2024$64.27$64.74+0.73%$65.23$64.0316,045 shs$943.91 million Related Companies: PBT Stock Price Chart PUMP Stock Price Chart SXC Stock Price Chart BORR Stock Price Chart CSIQ Stock Price Chart CAPL Stock Price Chart GRNT Stock Price Chart NESR Stock Price Chart PDS Stock Price Chart REX Stock Price Chart Receive SBR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sabine Royalty Trust and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:SBR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sabine Royalty Trust Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.